By: Don Seiffert From: bizjournals.com A year ago, Ziopharm was scarcely known in the biotech world, having recently moved from New York City to Charlestown just a couple years after one of its drugs failed a late-stage trial. Over the course of 2015, the company attracted worldwide notice for its early-stage treatments for cancer. In particular, attention has been on …
-
-
A Mother’s Day Gift for All Women
-
How We Learned “Acceptance”
-
The Destruction from Worrying
-
Happy Easter to Everyone
-
About Gratitude
